Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T22:15:53.578Z.
Calculation as of: 2026-10-06T22:15:53.578Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 098b8cc383d7c70bc2f58c50adf850e5cd93194028a42938ba247026a8eec5c0
EARNINGS YIELD
N/A
Market Cap
$1.63B
Earnings Yield
6.47%
TTM Avg
4.06%
3Y Avg
2.87%
5Y Avg
2.87%
Market Cap
$1.59B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.57B
Earnings Yield
N/A
TTM Avg
3.94%
3Y Avg
3.94%
5Y Avg
3.94%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | $1.62B | N/A | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | 6.47% | 4.06% | 2.87% | 2.87% |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 2.38% | 1.15% | 1.23% | 1.24% |
| Septerna Inc (SEPN)vs › | $1.61B | N/A | 6.67% | 6.67% | 6.67% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.61B | N/A | N/A | N/A | N/A |
| uniQure N.V. (QURE)vs › | $1.60B | N/A | 32.82% | 32.44% | 32.44% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | N/A | N/A | N/A | N/A |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | N/A | 3.94% | 3.94% | 3.94% |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.70B | N/A | N/A | N/A | N/A |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | N/A | 1.64% | 1.64% | 1.64% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
